Loading...
Loading...
India's antitoxin imports from INDONESIA total $984 across 2 shipments from 1 foreign suppliers. M/S. BIONET ASIA CO. LTD leads with $984 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include PANACEA BIOTEC LIMITED. This corridor reflects India's pharmaceutical import demand for antitoxin — a concentrated sourcing relationship with select suppliers from INDONESIA.

M/S. BIONET ASIA CO. LTD is the leading Antitoxin supplier from INDONESIA to India, with import value of $984 across 2 shipments. The top 5 suppliers — M/S. BIONET ASIA CO. LTD — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | M/S. BIONET ASIA CO. LTD | $984 | 2 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PANACEA BIOTEC LIMITED | $984 | 2 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Antitoxin suppliers from INDONESIA to India include M/S. BIONET ASIA CO. LTD. The leading supplier is M/S. BIONET ASIA CO. LTD with import value of $984 USD across 2 shipments. India imported Antitoxin worth $984 USD from INDONESIA in total across 2 shipments.
India imported Antitoxin worth $984 USD from INDONESIA across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Antitoxin sourced from INDONESIA include PANACEA BIOTEC LIMITED. The largest buyer is PANACEA BIOTEC LIMITED with $984 in imports across 2 shipments.
The total value of Antitoxin imports from INDONESIA to India is $984 USD, across 2 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists